|
![]() |
|||
|
||||
OverviewThere is increased global interest in radiolabelled biologicals for clinical applications. Influenced by the search for the biological bullet, a variety of strategies have evolved for radiolabelling biological products with a view to human health application. This publication describes the challenges that the in vivo use of these products brings and provides essentials from in vitro to in vivo validation in human investigations. Additional attention is paid to safety and the effective use of radiolabelled biologicals in a busy clinical setting. The publication will be a useful resource for nuclear medicine physicians, radiologists, radiopharmacists, pharmacologists and other researchers engaged with radiolabelling biologicals for clinical applications. Full Product DetailsAuthor: International Atomic Energy Agency (IAEA)Publisher: International Atomic Energy Agency Imprint: International Atomic Energy Agency ISBN: 9781282788053ISBN 10: 1282788051 Pages: 140 Publication Date: 29 January 2010 Audience: General/trade , General Format: Undefined Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |